Olivier Nègre

4.5k citations
24 papers · 596 indexed · h-index 13
Topics
Virus-based gene therapy research (11 papers)CRISPR and Genetic Engineering (9 papers)Hemoglobinopathies and Related Disorders (6 papers)

In The Last Decade

Olivier Nègre

24 papers receiving 586 citations

Peers

Olivier Nègre
Comparison fields: 5 of 72
  • Molecular Biology 429
  • Genetics 232
  • Genetics 198
  • Pediatrics, Perinatology and Child Health 91
  • Hematology 84
Replace Kanit Bhukhai with:
Kanit Bhukhai Thailand
A‐M Faussat France
A. Eigel Germany
Surinder Safaya United States
F E Cash United States
Sigrid H.W. Beiboer Netherlands
Raveen Basran Canada
Richard E. Broadberry Taiwan
Yuanxin Ye China
Hans‐Georg Eckert Germany
Olivier Nègre relative to Kanit Bhukhai Thailand Kanit Bhukhai's profile →
Citations per field
00.5×4.3×
Kanit Bhukhai · 1×
Citations per year

Countries citing papers authored by Olivier Nègre

Since Specialization
Citations

This map shows the geographic impact of Olivier Nègre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Nègre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Nègre more than expected).

Fields of papers citing papers by Olivier Nègre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Nègre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Nègre. The network helps show where Olivier Nègre may publish in the future.

Co-authorship network of co-authors of Olivier Nègre

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Nègre. A scholar is included among the top collaborators of Olivier Nègre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Nègre. Olivier Nègre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 2
3 1
4 2
5 9
6 87
7 63
8 13
9 3
10 45
11 16
12 121
13 1
14 14
15 55
16 19
17 1
18 3
19 52
20 41

About Olivier Nègre

Olivier Nègre is a scholar working on Hematology, Genetics and Genetics, having authored 24 papers that have together received 596 indexed citations. Recurring topics across this work include Virus-based gene therapy research (11 papers), CRISPR and Genetic Engineering (9 papers) and Hemoglobinopathies and Related Disorders (6 papers). The work is most often cited by research in Genetics (198 citations), Genetics (232 citations) and Hematology (84 citations). Olivier Nègre has collaborated with scholars based in France, United States and Thailand. Frequent co-authors include Emmanuel Payen, Philippe Leboulch, D Fradelizi, Yves Beuzard, David J. Rawlings, Sowmya Pattabhi, Christopher T. Lux, Andrew M. Scharenberg, Pierre‐Jacques Ferret and Suparerk Borwornpinyo. Their work appears in journals such as Blood, Biochemical Journal and Methods in enzymology on CD-ROM/Methods in enzymology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026